Among the T-cell markers, only the expression of CD4 was significantly upregulated in HNSCC compared to that in NOM, and its downstream pathway, the calcium signaling pathway, was also upregulated. The gene discussed is CD4; the disease is head and neck squamous cell carcinoma.